Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
oleh: Jonathan J. Park, PhD, Eunsuh Park, William E. Damsky, MD, PhD, Matthew D. Vesely, MD, PhD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-07-01 |
Deskripsi
Subjek
cancer immunotherapy; cutaneous immune related adverse events; dupilumab; immune checkpoint; lichen planus; lichenoid dermatitis